You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Parameter Development for the Scaled Manufacturing of Mycelium Bound Panels for Commercial Interior Products
SBC: Ecovative Design Llc Topic: 16NCER6AEcovative Design uses grown mycelium structures to bind agricultural and wood byproducts into inherently nontoxic_x000D_ products containing no added urea formaldehyde or flame-retardant chemicals. This research program focuses_x000D_ on maturing mycelium technology for use in the production of large scale board products, from low density (LD) particle board to acoustic panels and thermal insulati ...
SBIR Phase II 2018 Environmental Protection Agency -
An Enhanced Contact Plasma Reactor: A Competitive Remediation Technology for Per- and Perfluoroalkyl Substance (PFAS) Contaminated Water
SBC: DMAX PLASMA, INC. Topic: 17NCER1APerfluoroalkyl substances (PFASs) have received considerable attention due to their toxicity, ubiquitous presence and recalcitrance. Manufacture and disposal of PFAS-containing products has resulted in PFAS contamination of numerous water supplies. Recent reports indicate the Air Force alone is expecting to spend > $2.25 billion for cleanup for PFAS-contaminated sites. Thus, there is a huge market ...
SBIR Phase I 2018 Environmental Protection Agency -
Phytoremediation of perfluoroalkyl substances (PFAS) via phytoextraction
SBC: NUTTER & ASSOCIATES, INC. Topic: 17NCER3ANAI has a strategy to identify plant species best suited for proof-of-concept testing for phytoremediation of perfluoroalkyl substances (PFAS) via phytoextraction. Phytoextraction refers to the uptake and translocation of contaminants in the soil by plant roots into the aboveground portions of plants. Once the phytoextraction concepts are proven at the bench-scale (Phase I) and followed with succe ...
SBIR Phase I 2018 Environmental Protection Agency -
Green Process for Plastic Chrome
SBC: VERGASON TECHNOLOGY INC Topic: 17NCER5BThis green approach to manufacturing plastic with decorative chrome will eliminate health and environmental hazards from the chrome electroplating process. The US and global market for decorative chrome on plastic is 12 million m2/year and 84 million m2/year respectively, with 80% in automobile trim, 10% in appliances and 10% in sanitary fixtures. Without a viable commercial alternative, US provid ...
SBIR Phase I 2018 Environmental Protection Agency -
A Green Rooftop System for Commercial Buildings with Superior Energy Efficiency
SBC: XIMAX Technologies Corporation Ltd Topic: 17NCER6BThis proposed project will develop a highly modularized green rooftop system that is not only longlasting but also assemble-able/disassemble-able. At roofs' end-of-life, it can be disassembled and_x000D_ 100% recycled. At buildings' end-of-life, if the roof still has enough useable life, it can be disassembled and reused elsewhere. Major environmental benefits of this technology are 1) nothing fro ...
SBIR Phase I 2018 Environmental Protection Agency -
VGo-Assist, A Mobile Telepresence Robot to Engage Persons with Alzheimer's Disease and Related Dementias
SBC: VECNA TECHNOLOGIES, INC Topic: NIAPROJECT SUMMARY ABSTRACTThis project s long term purpose is to adapt an existing telepresence robotVecna s VGofor remote care of persons living at home with early stage Alzheimer s and related dementiasADRDIt responds to the NIA s call for development of robots to support care management and independent livingpromote social engagementreduce lonelinessand assist family members and professionals in ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Peripheral FAAH inhibitor, URB937, as an opioid-sparing analgesic for chronic pain.
SBC: ASPIREBIO CORP Topic: 101PROJECT SUMMARY Opioid drugs are powerful analgesicsbut their side effect profile strongly limits their useIndeedtheir addictive properties have led to an epidemic of abuse in the US that accounts forof the global utilization of prescription opioid analgesics in the USwith a market of over $billion per yearPrevious studies have shown that the endocannabinoid neurotransmitteranandamidecontrols noci ...
STTR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Enhanced Treatment Management of Opioid-Dependence in an Office-Based Setting
SBC: MedicaSafe Inc Topic: NIDAPROJECT SUMMARY ABSTRACT Opioid use disorder is the leading cause of accidental death in the USwith overlethal drug overdoses inSAMHSA estimates thatmillion Americans misuse prescription opioids for non medical purposes annuallyPublic health officials and policymakers have acknowledged the urgent need for innovative approaches to the treatment of those with opioid use disorderin spite of thisthe a ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Automated Assessment of Leptomeningeal Collaterals on CT Angiograms
SBC: KITWARE INC Topic: 108AbstractThe primary goal of this study is to develop an automated scoring system of leptomeningeal collaterals based on CT angiographyCTAas a quantitative assessment of acute ischemic strokeLeptomeningeal collaterals provide an alternate path of blood flow in the setting of a proximal vessel occlusionThe presence and effectiveness of leptomeningeal collateralsi ecollateral statusvaries significant ...
STTR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Tau oligomer platform validation using lead series candidate in htau mice
SBC: OLIGOMERIX INC Topic: NIATITLETau oligomer platform validation using lead series candidate in htau mice PROJECT SUMMARYSBIR Funding OpportunityAdvancing Research on Alzheimerandapos s DiseaseADand Alzheimerandapos s Disease Related DementiasADRDRRPASThe long term goal of this program is to develop a disease modifyingsmall molecule drug for Alzheimer s diseaseADand related tauopathiesThere is a critical unmet need for a di ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health